XML 64 R43.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Fair Value of Financial Instruments - Schedule of Quantitative Information of Fair Value Measurements (Details) - Significant Unobservable Inputs (Level 3) $ in Thousands | Dec. 31, 2023 USD ($) | Dec. 31, 2022 USD ($)
--- | --- | ---
Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | $ 3,057,299 | $ 2,795,444
Equity and Warrant Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | 116,916 | 85,966
Debt Investments And Other Investment Receivables |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | 3,066,947 |
Market Comparable Companies | Equity Securities |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | 52,094 | 30,086
Market Comparable Companies | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | 19,014 | 12,479
Market Comparable Companies | Pharmaceuticals | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | 971,775 | 903,427
Market Comparable Companies | Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | 1,181,823 | 967,108
Market Comparable Companies | Sustainable and Renewable Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | 1,678 | 3,006
Market Comparable Companies | Lower Middle Market | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | $ 322,162 | $ 328,393
Market Comparable Companies | Hypothetical Market Yield | Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.1503 |
Market Comparable Companies | Premium/(Discount) | Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input |  | 0.0020
Market Comparable Companies | Minimum | Hypothetical Market Yield | Pharmaceuticals | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.1091 | 0.1174
Market Comparable Companies | Minimum | Hypothetical Market Yield | Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.1130 | 0.1205
Market Comparable Companies | Minimum | Hypothetical Market Yield | Sustainable and Renewable Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.1075 | 0.1471
Market Comparable Companies | Minimum | Hypothetical Market Yield | Lower Middle Market | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.1254 | 0.1368
Market Comparable Companies | Minimum | Premium/(Discount) | Pharmaceuticals | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | (0.0100) | (0.0075)
Market Comparable Companies | Minimum | Premium/(Discount) | Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | (0.0100) | (0.0100)
Market Comparable Companies | Minimum | Premium/(Discount) | Sustainable and Renewable Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.0075 | 0.0075
Market Comparable Companies | Minimum | Premium/(Discount) | Lower Middle Market | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | (0.0075) | (0.0200)
Market Comparable Companies | Minimum | EBITDA Multiple | Equity Securities |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 12.3 | 12.4
Market Comparable Companies | Minimum | EBITDA Multiple | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 12.3 | 12.4
Market Comparable Companies | Minimum | Revenue Multiple | Equity Securities |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.3 | 0.7
Market Comparable Companies | Minimum | Revenue Multiple | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.9 | 0.6
Market Comparable Companies | Minimum | Tangible Book Value Multiple | Equity Securities |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 1.8 | 1.6
Market Comparable Companies | Minimum | Discount for Lack of Marketability | Equity Securities |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.0711 | 0.0811
Market Comparable Companies | Minimum | Discount for Lack of Marketability | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.0621 | 0.0811
Market Comparable Companies | Maximum | Hypothetical Market Yield | Pharmaceuticals | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.2143 | 0.1904
Market Comparable Companies | Maximum | Hypothetical Market Yield | Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.2074 | 0.1853
Market Comparable Companies | Maximum | Hypothetical Market Yield | Sustainable and Renewable Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.1075 | 0.1471
Market Comparable Companies | Maximum | Hypothetical Market Yield | Lower Middle Market | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.2015 | 0.1849
Market Comparable Companies | Maximum | Premium/(Discount) | Pharmaceuticals | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.0350 | 0.0175
Market Comparable Companies | Maximum | Premium/(Discount) | Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.0500 | 0.0150
Market Comparable Companies | Maximum | Premium/(Discount) | Sustainable and Renewable Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.0075 | 0.0075
Market Comparable Companies | Maximum | Premium/(Discount) | Lower Middle Market | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.0225 | 0.0075
Market Comparable Companies | Maximum | EBITDA Multiple | Equity Securities |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 12.3 | 12.4
Market Comparable Companies | Maximum | EBITDA Multiple | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 12.3 | 12.4
Market Comparable Companies | Maximum | Revenue Multiple | Equity Securities |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 20.1 | 16.1
Market Comparable Companies | Maximum | Revenue Multiple | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 10.2 | 8.8
Market Comparable Companies | Maximum | Tangible Book Value Multiple | Equity Securities |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 1.8 | 1.6
Market Comparable Companies | Maximum | Discount for Lack of Marketability | Equity Securities |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.9272 | 0.2890
Market Comparable Companies | Maximum | Discount for Lack of Marketability | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.3312 | 0.3270
Market Comparable Companies | Weighted Average | Hypothetical Market Yield | Pharmaceuticals | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.1346 | 0.1517
Market Comparable Companies | Weighted Average | Hypothetical Market Yield | Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input |  | 0.1521
Market Comparable Companies | Weighted Average | Hypothetical Market Yield | Sustainable and Renewable Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.1075 | 0.1471
Market Comparable Companies | Weighted Average | Hypothetical Market Yield | Lower Middle Market | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.1413 | 0.1482
Market Comparable Companies | Weighted Average | Premium/(Discount) | Pharmaceuticals | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.0004 | 0.0001
Market Comparable Companies | Weighted Average | Premium/(Discount) | Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.0047 |
Market Comparable Companies | Weighted Average | Premium/(Discount) | Sustainable and Renewable Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.0075 | 0.0075
Market Comparable Companies | Weighted Average | Premium/(Discount) | Lower Middle Market | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.0056 | (0.0043)
Market Comparable Companies | Weighted Average | EBITDA Multiple | Equity Securities |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 12.3 | 12.4
Market Comparable Companies | Weighted Average | EBITDA Multiple | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 12.3 | 12.4
Market Comparable Companies | Weighted Average | Revenue Multiple | Equity Securities |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 7.2 | 7.4
Market Comparable Companies | Weighted Average | Revenue Multiple | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 4.2 | 3.4
Market Comparable Companies | Weighted Average | Tangible Book Value Multiple | Equity Securities |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 1.8 | 1.6
Market Comparable Companies | Weighted Average | Discount for Lack of Marketability | Equity Securities |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.3157 | 0.1979
Market Comparable Companies | Weighted Average | Discount for Lack of Marketability | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.2170 | 0.1897
Income Approach | Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | $ 23,244 | $ 20,356
Income Approach | Minimum | Probability weighting of alternative outcomes | Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.0100 | 0.0100
Income Approach | Maximum | Probability weighting of alternative outcomes | Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.5000 | 0.5000
Income Approach | Weighted Average | Probability weighting of alternative outcomes | Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.3932 | 0.3579
Liquidation | Equity Securities |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments |  | $ 0
Liquidation | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments |  | 0
Liquidation | Pharmaceuticals | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | $ 8,455 |
Liquidation | Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | 0 | 1,671
Liquidation | Lower Middle Market | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments |  | $ 8,042
Liquidation | Other Investment Receivable | Other Investment Receivables |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | $ 9,648 |
Liquidation | Minimum | Probability weighting of alternative outcomes | Pharmaceuticals | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.1000 |
Liquidation | Minimum | Probability weighting of alternative outcomes | Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 1.0000 | 0.0500
Liquidation | Minimum | Probability weighting of alternative outcomes | Lower Middle Market | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input |  | 0.2000
Liquidation | Minimum | Probability weighting of alternative outcomes | Other Investment Receivable | Other Investment Receivables |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.1000 |
Liquidation | Minimum | Revenue Multiple | Equity Securities |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input |  | 2.1
Liquidation | Minimum | Revenue Multiple | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input |  | 6.2
Liquidation | Minimum | Discount for Lack of Marketability | Equity Securities |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input |  | 0.8500
Liquidation | Minimum | Discount for Lack of Marketability | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input |  | 90.00
Liquidation | Maximum | Probability weighting of alternative outcomes | Pharmaceuticals | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.5000 |
Liquidation | Maximum | Probability weighting of alternative outcomes | Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 1.0000 | 0.8000
Liquidation | Maximum | Probability weighting of alternative outcomes | Lower Middle Market | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input |  | 0.8000
Liquidation | Maximum | Probability weighting of alternative outcomes | Other Investment Receivable | Other Investment Receivables |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.5000 |
Liquidation | Maximum | Revenue Multiple | Equity Securities |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input |  | 2.1
Liquidation | Maximum | Revenue Multiple | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input |  | 6.2
Liquidation | Maximum | Discount for Lack of Marketability | Equity Securities |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input |  | 0.8500
Liquidation | Maximum | Discount for Lack of Marketability | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input |  | 90.00
Liquidation | Weighted Average | Probability weighting of alternative outcomes | Pharmaceuticals | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.4183 |
Liquidation | Weighted Average | Probability weighting of alternative outcomes | Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 1.0000 | 0.4829
Liquidation | Weighted Average | Probability weighting of alternative outcomes | Lower Middle Market | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input |  | 0.8000
Liquidation | Weighted Average | Probability weighting of alternative outcomes | Other Investment Receivable | Other Investment Receivables |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.4183 |
Liquidation | Weighted Average | Revenue Multiple | Equity Securities |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input |  | 2.1
Liquidation | Weighted Average | Revenue Multiple | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input |  | 6.2
Liquidation | Weighted Average | Discount for Lack of Marketability | Equity Securities |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input |  | 0.8500
Liquidation | Weighted Average | Discount for Lack of Marketability | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input |  | 90.00
Cost Approach | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | $ 431,512 | $ 392,168
Debt Investments Imminent Payoffs | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | 54,430 | 77,676
Debt Maturing Within One Year | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | 62,220 | 93,597
Market Adjusted OPM Backsolve | Equity Securities |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | 11,096 | 13,795
Market Adjusted OPM Backsolve | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | $ 3,074 | $ 6,934
Market Adjusted OPM Backsolve | Minimum | Market Equity Adjustment | Equity Securities |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | (0.8614) | (0.9782)
Market Adjusted OPM Backsolve | Minimum | Market Equity Adjustment | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | (0.7067) | (0.9782)
Market Adjusted OPM Backsolve | Maximum | Market Equity Adjustment | Equity Securities |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.3269 | 0.1634
Market Adjusted OPM Backsolve | Maximum | Market Equity Adjustment | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.3486 | 0.6643
Market Adjusted OPM Backsolve | Weighted Average | Market Equity Adjustment | Equity Securities |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.0747 | (0.1669)
Market Adjusted OPM Backsolve | Weighted Average | Market Equity Adjustment | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.1317 | (0.0886)
Discounted Cash Flow | Equity Securities |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | $ 28,713 | $ 19,153
Discounted Cash Flow | Minimum | Discount Rate | Equity Securities |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.1988 | 0.1772
Discounted Cash Flow | Maximum | Discount Rate | Equity Securities |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.3197 | 0.3013
Discounted Cash Flow | Weighted Average | Discount Rate | Equity Securities |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.3051 | 0.2446
Other | Equity Securities |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | $ 2,925 | $ 3,513
Other | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | $ 0 | $ 6

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Value of input used to measure investment owned by investment company. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
Namespace Prefix: | us-gaap_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_InvestmentsFairValueDisclosure
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=htgc_DebtInvestmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=htgc_EquityAndWarrantInvestmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=htgc_DebtInvestmentsAndOtherInvestmentReceivablesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ValuationTechniqueAxis=htgc_ValuationTechniqueMarketComparableCompaniesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=htgc_PharmaceuticalsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=htgc_TechnologyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=htgc_SustainableAndRenewableTechnologyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=htgc_LowerMiddleMarketMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=htgc_MeasurementInputHypotheticalMarketYieldMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=htgc_MeasurementInputPremiumDiscountNettingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputEbitdaMultipleMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRevenueMultipleMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=htgc_MeasurementInputTangibleBookValueMultipleMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_WeightedAverageMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ValuationTechniqueAxis=us-gaap_IncomeApproachValuationTechniqueMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=htgc_MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ValuationTechniqueAxis=htgc_ValuationTechniqueLiquidationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=htgc_OtherInvestmentReceivableMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=htgc_OtherInvestmentReceivablesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ValuationTechniqueAxis=us-gaap_CostApproachValuationTechniqueMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ValuationTechniqueAxis=htgc_DebtInvestmentsImminentPayoffsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ValuationTechniqueAxis=htgc_DebtMaturingWithinOneYearMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=htgc_MeasurementInputMarketEquityAdjustmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ValuationTechniqueAxis=htgc_ValuationTechniqueOtherMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |